Chronic supplementation with the mitochondria-targeted antioxidant MitoQ in older adults reduces oxidized low-density lipoprotein, enhances nitric oxide production, and reduces oxidative stress.
Does chronic MitoQ supplementation alter the circulating milieu to improve endothelial cell function and reduce mitochondrial oxidative stress in older adults?
Chronic MitoQ supplementation improves age-related endothelial dysfunction by reducing oxidized LDL, enhancing nitric oxide production, and lowering mitochondrial oxidative stress.
Chronic supplementation with a mitochondria-targeted antioxidant (MitoQ) improves vascular endothelial function in older adults, but the mechanisms of action are incompletely understood. Here, we show that MitoQ supplementation leads to changes in the circulating milieu (plasma), including reductions in oxidized low-density lipoprotein that enhance nitric oxide production and reduce mitochondrial oxidative stress in endothelial cells. These findings provide new information regarding the mechanisms by which MitoQ improves age-related endothelial dysfunction.
Murray et al. (Fri,) conducted a other in Age-related endothelial dysfunction. Mitochondria-targeted antioxidant (MitoQ) was evaluated on Changes in the circulating milieu (plasma), oxidized low-density lipoprotein, nitric oxide production, and mitochondrial oxidative stress. Chronic supplementation with the mitochondria-targeted antioxidant MitoQ in older adults reduces oxidized low-density lipoprotein, enhances nitric oxide production, and reduces oxidative stress.